Live Breaking News & Updates on Gurses Ozden

Stay updated with breaking news from Gurses ozden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ocular Therapeutix™ To Present 12-Month Top-Line Data from U.S.-Based Phase 1 Clinical Trial of OTX-TKI in Wet Age-Related Macular Degeneration at the 2023 Clinical Trials at the Summit Annual Meeting

BEDFORD, Mass., June 05, 2023 Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and. | June 5, 2023 ....

Park City , United States , Arshadm Khanani , Jeffrey Heier , Peterk Kaiser , Reenie Mccarthy , Alexander Hardy , Chris Brinzey , Joel Naor , Mohamed Genead , Rabia Gurses Ozden , Donald Notman , Antony Mattessich , Victor Perlroth , Exchange Commission , Globenewswire Inc , Ocular Therapeutix Inc , Sierra Eye Associates , Clinical Research , Ophthalmology Research , Vitreoretinal Service , Retina Research , Cleveland Clinic Lerner College Of Medicine , Summit Annual Meeting , Clinical Trials , Gurses Ozden ,

Ocular Therapeutix™ Announces Organizational Changes to Support Development for Retinal Diseases

Peter K. Kaiser, M.D., a world-renowned ophthalmologist and retinal disease expert, to serve as Chief Medical Advisor – RetinaRabia Gurses Ozden, M.D. promoted to Chief Medical OfficerMichael Goldstein, M.D. to transition from Chief Medical Officer and President Ophthalmology to Chief Strategy AdvisorBEDFORD, Mass.-. ....

United States , Scott Corning , Antony Mattessich , Gurses Ozden , Michael Goldstein , Rabia Gurses Ozden , Chris Brinzey , Peterk Kaiser , Lewr Wasserman , Donald Notman , American Society Of Retina Specialists Honor , Bascom Palmer Eye Institute , Ophthalmology Research , Ocular Therapeutix Inc , Company On , Cleveland Clinic Foundation , Clinical Development , Editor Of International Ophthalmology Clinics , Senior Leadership Team , Cleveland Clinic Lerner College Of Medicine , Harvard Medical School , Macula Society Young Investigator Award , Company Senior Vice , Exchange Commission , Research To Prevent Blindness , Akouos Inc ,

Adverum Biotechnologies Reports First Quarter 2022 Financial Results

12.05.2022 - REDWOOD CITY, Calif., May 12, 2022 (GLOBE NEWSWIRE) - Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today reported financial results for the first . ....

Sooj Hong , Richard Beckman , Laurence Watts , Cone Monochromacy , Anand Reddi , Rabia Gurses Ozden , Adverum Biotechnologies Inc , American Society Of Gene Cell Therapy , Drug Administration , Exchange Commission , Affairs Engagement , Gilmartin Group , Corporate Communications , Association For Research , Orphan Drug Designation , Star Seyedkazemi , Gurses Ozden , Investigational New Drug , American Society , Cell Therapy , Three Months Ended March , Private Securities Litigation Reform , Annual Report , Corporate Strategy , External Affairs ,